The persistently high tumor uptake of PSMA-NARI-56 is attributed to slower blood clearance and enhanced interactions with albumin, which reduce the steric accessibility of PSMA ligands by metabolizing enzymes, and thus may have higher metabolic stability. The gene discussed is FOLH1; the disease is neoplasm.